应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IMCR Immunocore Holdings plc
未开盘 08-15 16:00:00 EDT
36.75
-0.22
-0.60%
盘后
36.75
+0.00
0.00%
16:32 EDT
最高
37.37
最低
36.43
成交量
34.27万
今开
37.25
昨收
36.97
日振幅
2.54%
总市值
18.38亿
流通市值
14.95亿
总股本
5,002万
成交额
1,265万
换手率
0.84%
流通股本
4,068万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Immunocore Hldgs Plc盘中异动 早盘股价大跌6.17%报36.51美元
自选股智能写手 · 08-05
Immunocore Hldgs Plc盘中异动 早盘股价大跌6.17%报36.51美元
Immunocore Hldgs Plc盘中异动 早盘股价大跌6.49%
自选股智能写手 · 08-02
Immunocore Hldgs Plc盘中异动 早盘股价大跌6.49%
Immunocore Hldgs Plc盘中异动 股价大跌5.03%
自选股智能写手 · 07-18
Immunocore Hldgs Plc盘中异动 股价大跌5.03%
Immunocore Hldgs Plc盘中异动 股价大涨5.14%报41.50美元
自选股智能写手 · 07-17
Immunocore Hldgs Plc盘中异动 股价大涨5.14%报41.50美元
Immunocore Hldgs Plc盘中异动 股价大跌5.06%报34.59美元
自选股智能写手 · 07-03
Immunocore Hldgs Plc盘中异动 股价大跌5.06%报34.59美元
Immunocore Hldgs Plc盘中异动 急速拉升5.05%
自选股智能写手 · 07-01
Immunocore Hldgs Plc盘中异动 急速拉升5.05%
Immunocore Hldgs Plc盘中异动 早盘股价大跌5.25%报46.41美元
自选股智能写手 · 06-03
Immunocore Hldgs Plc盘中异动 早盘股价大跌5.25%报46.41美元
Immunocore Hldgs Plc盘中异动 股价大涨5.01%
自选股智能写手 · 06-01
Immunocore Hldgs Plc盘中异动 股价大涨5.01%
HC Wainwright & Co.:重申Immunocore Hldgs(IMCR.US)评级,由买入调整至买入评级, 目标价100.
智通财经 · 05-25
HC Wainwright & Co.:重申Immunocore Hldgs(IMCR.US)评级,由买入调整至买入评级, 目标价100.
Immunocore Hldgs Plc盘中异动 早盘股价大跌12.46%报42.00美元
自选股智能写手 · 05-24
Immunocore Hldgs Plc盘中异动 早盘股价大跌12.46%报42.00美元
Immunocore Hldgs(IMCR.US):2024年Q1财报实现营收7050.2万美元,前值为5509.3万美元,预期值为7115万美元;
智通财经 · 05-08
Immunocore Hldgs(IMCR.US):2024年Q1财报实现营收7050.2万美元,前值为5509.3万美元,预期值为7115万美元;
Immunocore Hldgs(IMCR.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价74.
智通财经 · 04-29
Immunocore Hldgs(IMCR.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价74.
Needham:重申Immunocore Hldgs(IMCR.US)评级,由买入调整至买入评级, 目标价81.00美元。
智通财经 · 04-11
Needham:重申Immunocore Hldgs(IMCR.US)评级,由买入调整至买入评级, 目标价81.00美元。
Immunocore Hldgs Plc盘中异动 急速下跌5.13%
自选股智能写手 · 04-09
Immunocore Hldgs Plc盘中异动 急速下跌5.13%
Immunocore Hldgs Plc2023财年实现净利润-55.50百万美元,同比减少9.29%
自选股智能写手 · 03-04
Immunocore Hldgs Plc2023财年实现净利润-55.50百万美元,同比减少9.29%
奥本海默:重申Immunocore Hldgs(IMCR.US)评级,由优于大市调整至优于大市评级, 目标价由85.00美元调整至87.
智通财经 · 02-29
奥本海默:重申Immunocore Hldgs(IMCR.US)评级,由优于大市调整至优于大市评级, 目标价由85.00美元调整至87.
Needham:重申Immunocore Hldgs(IMCR.US)评级,由买入调整至买入评级, 目标价81.00美元。
智通财经 · 02-29
Needham:重申Immunocore Hldgs(IMCR.US)评级,由买入调整至买入评级, 目标价81.00美元。
公司概况
公司名称:
Immunocore Holdings plc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Immunocore Holdings plc根据英格兰和威尔士法律于2021年1月7日成立。这是一家后期生物技术公司,致力于开发新型I类TCR双特异性免疫疗法,即ImmTAX–针对X病的免疫动员单克隆TCR。 可治疗多种疾病,包括癌症,传染性疾病和自身免疫性疾病。借助其专有的,灵活的,现成的ImmTAX平台,他们正在多个治疗领域中开发深层次的产品,包括五个在肿瘤学和传染病方面的临床阶段计划,在自身免疫性疾病中进行的高级临床前计划以及多个早期的临床前计划程式。
发行价格:
--
{"stockData":{"symbol":"IMCR","market":"US","secType":"STK","nameCN":"Immunocore Holdings plc","latestPrice":36.75,"timestamp":1723752000000,"preClose":36.97,"halted":0,"volume":342731,"hourTrading":{"tag":"盘后","latestPrice":36.75,"preClose":36.75,"latestTime":"16:32 EDT","volume":3890,"amount":142974.24,"timestamp":1723753935382},"delay":0,"floatShares":40683560,"shares":50018756,"eps":-1.105452,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.22,"latestTime":"08-15 16:00:00 EDT","open":37.25,"high":37.37,"low":36.43,"amount":12654056.93375,"amplitude":0.025426,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.105452,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1723795200000},"adr":0,"listingDate":1612501200000,"adjPreClose":36.97,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":37.08,"preClose":36.97,"latestTime":"09:29 EDT","volume":454,"amount":16910.320508,"timestamp":1723728599235},"postHourTrading":{"tag":"盘后","latestPrice":36.75,"preClose":36.75,"latestTime":"16:32 EDT","volume":3890,"amount":142974.24,"timestamp":1723753935382},"volumeRatio":0.9389015821562794,"impliedVol":0.6952,"impliedVolPercentile":0.8765},"requestUrl":"/m/hq/s/IMCR/wiki","defaultTab":"wiki","newsList":[{"id":"2457720473","title":"Immunocore Hldgs Plc盘中异动 早盘股价大跌6.17%报36.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457720473","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457720473?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:33","pubTimestamp":1722864813,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时33分,Immunocore Hldgs Plc股票出现波动,股价急速下跌6.17%。截至发稿,该股报36.51美元/股,成交量1405股,换手率0.00%,振幅0.00%。Immunocore Hldgs Plc股票所在的生物技术行业中,整体跌幅为1.67%。Immunocore Hldgs Plc公司简介:Immunocore Holdings PLC是一家后期生物技术公司,致力于开发用于治疗癌症,传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213333af95fa37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213333af95fa37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","IMCR"],"gpt_icon":0},{"id":"2456844492","title":"Immunocore Hldgs Plc盘中异动 早盘股价大跌6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456844492","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456844492?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:31","pubTimestamp":1722605490,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时31分,Immunocore Hldgs Plc股票出现异动,股价急速下跌6.49%。截至发稿,该股报37.05美元/股,成交量2802股,换手率0.01%,振幅1.94%。Immunocore Hldgs Plc股票所在的生物技术行业中,整体跌幅为0.74%。Immunocore Hldgs Plc公司简介:Immunocore Holdings PLC是一家后期生物技术公司,致力于开发用于治疗癌症,传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213130af95a594&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213130af95a594&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMCR","BK4139","BK4505"],"gpt_icon":0},{"id":"2452939911","title":"Immunocore Hldgs Plc盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452939911","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452939911?lang=zh_cn&edition=full","pubTime":"2024-07-18 01:58","pubTimestamp":1721239096,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日01时58分,Immunocore Hldgs Plc股票出现波动,股价快速跳水5.03%。截至发稿,该股报39.41美元/股,成交量29.5289万股,换手率0.59%,振幅4.87%。Immunocore Hldgs Plc股票所在的生物技术行业中,整体跌幅为1.79%。Immunocore Hldgs Plc公司简介:Immunocore Holdings PLC是一家后期生物技术公司,致力于开发用于治疗癌症,传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718015816941f7f9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718015816941f7f9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMCR","BK4139","BK4505"],"gpt_icon":0},{"id":"2452944277","title":"Immunocore Hldgs Plc盘中异动 股价大涨5.14%报41.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452944277","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452944277?lang=zh_cn&edition=full","pubTime":"2024-07-17 03:30","pubTimestamp":1721158217,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日03时30分,Immunocore Hldgs Plc股票出现波动,股价快速拉升5.14%。截至发稿,该股报41.50美元/股,成交量31.2434万股,换手率0.62%,振幅5.19%。Immunocore Hldgs Plc股票所在的生物技术行业中,整体涨幅为0.32%。Immunocore Hldgs Plc公司简介:Immunocore Holdings PLC是一家后期生物技术公司,致力于开发用于治疗癌症,传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170330179681d451&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170330179681d451&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMCR","BK4505"],"gpt_icon":0},{"id":"2448167251","title":"Immunocore Hldgs Plc盘中异动 股价大跌5.06%报34.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448167251","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448167251?lang=zh_cn&edition=full","pubTime":"2024-07-03 01:36","pubTimestamp":1719941772,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日01时36分,Immunocore Hldgs Plc股票出现异动,股价急速跳水5.06%。截至发稿,该股报34.59美元/股,成交量12.7424万股,换手率0.25%,振幅6.49%。Immunocore Hldgs Plc股票所在的生物技术行业中,整体跌幅为1.14%。Immunocore Hldgs Plc公司简介:Immunocore Holdings PLC是一家后期生物技术公司,致力于开发用于治疗癌症,传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703013613aef79ca2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703013613aef79ca2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS","BK4505","IMCR"],"gpt_icon":0},{"id":"2448917570","title":"Immunocore Hldgs Plc盘中异动 急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448917570","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448917570?lang=zh_cn&edition=full","pubTime":"2024-07-01 23:55","pubTimestamp":1719849346,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日23时55分,Immunocore Hldgs Plc股票出现异动,股价快速拉升5.05%。Immunocore Hldgs Plc股票所在的生物技术行业中,整体涨幅为0.68%。Immunocore Hldgs Plc公司简介:Immunocore Holdings PLC是一家后期生物技术公司,致力于开发用于治疗癌症,传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701235546aef77078&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701235546aef77078&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMCR","BK4139","BK4505"],"gpt_icon":0},{"id":"2440215493","title":"Immunocore Hldgs Plc盘中异动 早盘股价大跌5.25%报46.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440215493","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440215493?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:31","pubTimestamp":1717421514,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时31分,Immunocore Hldgs Plc股票出现波动,股价急速跳水5.25%。截至发稿,该股报46.41美元/股,成交量2.3588万股,换手率0.05%,振幅3.33%。Immunocore Hldgs Plc股票所在的生物技术行业中,整体跌幅为0.35%。Immunocore Hldgs Plc公司简介:Immunocore Holdings PLC是一家后期生物技术公司,致力于开发用于治疗癌症,传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213154af8ba6cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213154af8ba6cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","IMCR"],"gpt_icon":0},{"id":"2440194058","title":"Immunocore Hldgs Plc盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440194058","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440194058?lang=zh_cn&edition=full","pubTime":"2024-06-01 03:57","pubTimestamp":1717185475,"startTime":"0","endTime":"0","summary":"北京时间2024年06月01日03时57分,Immunocore Hldgs Plc股票出现波动,股价急速上涨5.01%。截至发稿,该股报49.05美元/股,成交量100.705万股,换手率2.01%,振幅5.52%。Immunocore Hldgs Plc股票所在的生物技术行业中,整体涨幅为1.33%。Immunocore Hldgs Plc公司简介:Immunocore Holdings PLC是一家后期生物技术公司,致力于开发用于治疗癌症,传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601035755968112d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601035755968112d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","IMCR"],"gpt_icon":0},{"id":"2438905001","title":"HC Wainwright & Co.:重申Immunocore Hldgs(IMCR.US)评级,由买入调整至买入评级, 目标价100.","url":"https://stock-news.laohu8.com/highlight/detail?id=2438905001","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438905001?lang=zh_cn&edition=full","pubTime":"2024-05-25 00:40","pubTimestamp":1716568802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4505","IMCR"],"gpt_icon":0},{"id":"2437030301","title":"Immunocore Hldgs Plc盘中异动 早盘股价大跌12.46%报42.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437030301","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437030301?lang=zh_cn&edition=full","pubTime":"2024-05-24 21:31","pubTimestamp":1716557507,"startTime":"0","endTime":"0","summary":"北京时间2024年05月24日21时31分,Immunocore Hldgs Plc股票出现异动,股价大幅下跌12.46%。截至发稿,该股报42.00美元/股,成交量7.7025万股,换手率0.15%,振幅7.59%。Immunocore Hldgs Plc股票所在的生物技术行业中,整体跌幅为0.06%。Immunocore Hldgs Plc公司简介:Immunocore Holdings PLC是一家后期生物技术公司,致力于开发用于治疗癌症,传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242131479ee31302&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242131479ee31302&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMCR","BK4505"],"gpt_icon":0},{"id":"2433729432","title":"Immunocore Hldgs(IMCR.US):2024年Q1财报实现营收7050.2万美元,前值为5509.3万美元,预期值为7115万美元;","url":"https://stock-news.laohu8.com/highlight/detail?id=2433729432","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433729432?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:36","pubTimestamp":1715175396,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4505","IMCR"],"gpt_icon":0},{"id":"2431505368","title":"Immunocore Hldgs(IMCR.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价74.","url":"https://stock-news.laohu8.com/highlight/detail?id=2431505368","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431505368?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:00","pubTimestamp":1714395649,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IMCR","BK4139","BK4505"],"gpt_icon":0},{"id":"2426387237","title":"Needham:重申Immunocore Hldgs(IMCR.US)评级,由买入调整至买入评级, 目标价81.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426387237","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426387237?lang=zh_cn&edition=full","pubTime":"2024-04-11 18:45","pubTimestamp":1712832332,"startTime":"0","endTime":"0","summary":"Needham:重申Immunocore Hldgs(IMCR.US)评级,由买入调整至买入评级, 目标价81.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411184535876734da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411184535876734da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMCR"],"gpt_icon":0},{"id":"2426923105","title":"Immunocore Hldgs Plc盘中异动 急速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426923105","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426923105?lang=zh_cn&edition=full","pubTime":"2024-04-09 03:49","pubTimestamp":1712605779,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日03时49分,Immunocore Hldgs Plc股票出现异动,股价大幅下挫5.13%。截至发稿,该股报60.24美元/股,成交量16.0774万股,换手率0.32%,振幅5.61%。Immunocore Hldgs Plc股票所在的生物技术行业中,整体涨幅为0.18%。Immunocore Hldgs Plc公司简介:Immunocore Holdings PLC是一家后期生物技术公司,致力于开发用于治疗癌症,传染性疾病和自身免疫性疾病的新型TCR双特异性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409034939861e3fbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409034939861e3fbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LGVN","IMCR","BK4505"],"gpt_icon":0},{"id":"2416906719","title":"Immunocore Hldgs Plc2023财年实现净利润-55.50百万美元,同比减少9.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416906719","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2416906719?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:19","pubTimestamp":1709482744,"startTime":"0","endTime":"0","summary":"12月31日,Immunocore Hldgs Plc公布财报,公告显示公司2023财年净利润为-55.50百万美元,同比减少9.29%;其中营业收入为2.50亿美元,同比增加41.24%,每股基本收益为-1.14美元。从资产负债表来看,Immunocore Hldgs Plc总负债2.28亿美元,其中短期债务1.39百万美元,资产负债比为2.62,流动比率为3.81。机构评级:截至2023年12月31日,当前有15家机构对Immunocore Hldgs Plc目标价做出预测,其中目标均价为85.13美元,其中最低目标价为63.00美元,最高目标价为92.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400191387e0de6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400191387e0de6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMCR"],"gpt_icon":0},{"id":"2416522183","title":"奥本海默:重申Immunocore Hldgs(IMCR.US)评级,由优于大市调整至优于大市评级, 目标价由85.00美元调整至87.","url":"https://stock-news.laohu8.com/highlight/detail?id=2416522183","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2416522183?lang=zh_cn&edition=full","pubTime":"2024-02-29 23:41","pubTimestamp":1709221266,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4505","IMCR"],"gpt_icon":0},{"id":"2415752513","title":"Needham:重申Immunocore Hldgs(IMCR.US)评级,由买入调整至买入评级, 目标价81.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2415752513","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2415752513?lang=zh_cn&edition=full","pubTime":"2024-02-29 18:06","pubTimestamp":1709201208,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IMCR","BK4505","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunocore.com","stockEarnings":[{"period":"1week","weight":-0.0309},{"period":"1month","weight":-0.1142},{"period":"3month","weight":-0.3104},{"period":"6month","weight":-0.4749},{"period":"1year","weight":-0.3843},{"period":"ytd","weight":-0.4621}],"compareEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":-0.0209},{"period":"3month","weight":0.0446},{"period":"6month","weight":0.1072},{"period":"1year","weight":0.258},{"period":"ytd","weight":0.1636}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immunocore Holdings plc根据英格兰和威尔士法律于2021年1月7日成立。这是一家后期生物技术公司,致力于开发新型I类TCR双特异性免疫疗法,即ImmTAX–针对X病的免疫动员单克隆TCR。 可治疗多种疾病,包括癌症,传染性疾病和自身免疫性疾病。借助其专有的,灵活的,现成的ImmTAX平台,他们正在多个治疗领域中开发深层次的产品,包括五个在肿瘤学和传染病方面的临床阶段计划,在自身免疫性疾病中进行的高级临床前计划以及多个早期的临床前计划程式。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.069709},{"month":2,"riseRate":0,"avgChangeRate":-0.065247},{"month":3,"riseRate":0.25,"avgChangeRate":0.025389},{"month":4,"riseRate":0.5,"avgChangeRate":0.030449},{"month":5,"riseRate":0.25,"avgChangeRate":-0.083793},{"month":6,"riseRate":0.5,"avgChangeRate":0.011757},{"month":7,"riseRate":0.75,"avgChangeRate":0.086601},{"month":8,"riseRate":0.5,"avgChangeRate":-0.005169},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.038729},{"month":10,"riseRate":0.666667,"avgChangeRate":0.037302},{"month":11,"riseRate":0.666667,"avgChangeRate":0.073721},{"month":12,"riseRate":0.333333,"avgChangeRate":0.051882}],"exchange":"NASDAQ","name":"Immunocore Holdings plc","nameEN":"Immunocore Holdings plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunocore Holdings plc(IMCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immunocore Holdings plc(IMCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immunocore Holdings plc,IMCR,Immunocore Holdings plc股票,Immunocore Holdings plc股票老虎,Immunocore Holdings plc股票老虎国际,Immunocore Holdings plc行情,Immunocore Holdings plc股票行情,Immunocore Holdings plc股价,Immunocore Holdings plc股市,Immunocore Holdings plc股票价格,Immunocore Holdings plc股票交易,Immunocore Holdings plc股票购买,Immunocore Holdings plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunocore Holdings plc(IMCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immunocore Holdings plc(IMCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}